Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

You might be interested in: therapeutics, drug, cancer, more »

271-320 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

MarketVIEW: Parkinson's disease

MarketVIEW: Parkinson's disease

  • $ 3 995
  • Industry report
  • April 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Parkinson's disease is a degenerative disorder of the central nervous system where main symptoms are tremor at rest, stiffness, slowing of movement and postural instability. It is estimated that 6.3 million ...

  • Industries : Pathology
  • Countries : United Kingdom, United States, World, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe
Asia-Pacific Contrast Media Injectors Market Outlook to 2020

Asia-Pacific Contrast Media Injectors Market Outlook to 2020

  • $ 3 000
  • Industry report
  • March 2014
  • by Global Data

Asia-Pacific Contrast Media Injectors Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Contrast Media Injectors Market Outlook to 2020", provides key market data on the Asia-Pacific ...

  • Industries : Drug Delivery Technology
  • Countries : South Korea, Australia, Japan, India, China, Asia, World, Oceania
Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available ...

  • Industries : Drug and Medication
  • Countries : Australia, Germany, World, Canada, Spain, Italy, France, Japan, Oceania, New Zealand, Europe, United States, United Kingdom
Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Canada, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • March 2014
  • by Global Data

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Canada, Spain, Italy, France, Germany, United States, United Kingdom, Europe
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) ...

  • Industries : Drug and Medication
  • Countries : Australia
PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 10 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Canada, Spain, Italy, United Kingdom, France, Germany, Japan, United States, Europe
Australia Contrast Media Injectors Market Outlook to 2020

Australia Contrast Media Injectors Market Outlook to 2020

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Australia Contrast Media Injectors Market Outlook to 2020 Summary GlobalData's new report, "Australia Contrast Media Injectors Market Outlook to 2020", provides key market data on the Australia Contrast ...

  • Industries : Drug Delivery Technology
  • Countries : Australia
Zoll Medical Corporation - Strategic SWOT Analysis Review

Zoll Medical Corporation - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2014
  • by Global Data

Zoll Medical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : Pathology
  • Countries : Japan, World, Australia, Netherlands
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

  • $ 3 500
  • Industry report
  • March 2014
  • by GBI Research

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World, China, Australia, India, Japan, Asia
World Drug and Medication: Epilepsy – Pipeline Review, H1 2012

World Drug and Medication: Epilepsy – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Epilepsy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Pathology
  • Countries : Australia, World
EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2014
  • by Global Data

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023 Summary Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of ...

  • Industries : Pathology
  • Countries : World, Australia, Spain, Italy, France, Germany, Japan
New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: New Zealand has slipped ranks in our latest Risk/Reward Ratings – falling behind India due to the fact its small pharmaceutical industry is not as attractive as India’s industry for multinational ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Vitamin and Supplement Manufacturing in Australia - Industry Market Research Report

Vitamin and Supplement Manufacturing in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • February 2014
  • by Ibisworld

Healthy and functional: Health awareness and product innovation are driving industry growth Vitamin and Supplement Manufacturing in Australia Vitamin and supplement manufacturers primarily develop and ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
Australia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Australia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Australia’s pharmaceutical segment will get increasingly more regulated as the government seeks to make improvements for creating a more transparent environment, benefiting all stakeholders: ...

  • Industries : Drug and Medication
  • Countries : Australia
Australia Pharmaceuticals and Healthcare Report Q1 2014

Australia Pharmaceuticals and Healthcare Report Q1 2014

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We maintain our broad view toward Australia's pharmaceutical and healthcare sectors, as new Prime Minister Tony Abbott stated that 'there will be no cuts to ...

  • Industries : Drug and Medication
  • Countries : Australia
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

  • $ 3 500
  • Industry report
  • January 2014
  • by GBI Research

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : World, Australia, Japan, India, China
Chemical & Pharmaceutical Plants Construction in New Zealand to 2017: Market Databook

Chemical & Pharmaceutical Plants Construction in New Zealand to 2017: Market Databook

  • $ 500
  • Industry report
  • January 2014
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plants Construction in New Zealand to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Orphan Australia Pty Ltd (Orphan Australia) is a pharmaceutical company. The company provides novel therapies for the treatment of serious or life-threatening diseases in Australia and New Zealand. ...

  • Industries : Pharmaceutical
  • Countries : Australia
Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits

Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Avexa Limited (Symbol:AVX) SWOT Analysis, Strategy, Revenues and Profits

Avexa Limited (Symbol:AVX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia
Ministry of Health, New Zealand - Strategic SWOT Analysis Review

Ministry of Health, New Zealand - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Ministry of Health, New Zealand - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Pathology
  • Countries : New Zealand
Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review

Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Drug Delivery Technology
  • Countries : China, United States, Australia, Malaysia
Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia, South Africa, World, Brazil, Mexico, Germany, Tanzania, Kenya, Africa, Venezuela, Mauritius
IDT Australia Limited (Symbol:IDT) SWOT Analysis, Strategy, Revenues and Profits

IDT Australia Limited (Symbol:IDT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia
Antisense Therapeutics Limited (Symbol:ANP) SWOT Analysis, Strategy, Revenues and Profits

Antisense Therapeutics Limited (Symbol:ANP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Australia, United States
Hexima Limited - Strategic SWOT Analysis Review

Hexima Limited - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Hexima Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, ...

  • Industries : Drug Delivery Technology
  • Countries : Australia
Sigma Pharmaceuticals Limited - Strategy and SWOT Report

Sigma Pharmaceuticals Limited - Strategy and SWOT Report

  • $ 175
  • Company report
  • January 2014
  • by MarketLine

Sigma Pharmaceuticals Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmaceuticals Market Analysis in Australia: ISIC 2423

Pharmaceuticals Market Analysis in Australia: ISIC 2423

  • $ 599
  • Industry report
  • January 2014
  • by Euromonitor International

Euromonitor International's Industrial reports provide a 360 degree view of an market . The Industrial industry report offers a comprehensive guide to the size and shape of the Pharmaceuticalsmarket at ...

  • Industries : Pharmaceutical
  • Countries : Australia
Genera Biosystems Limited (GBI) - Product Pipeline Analysis, 2013 Update

Genera Biosystems Limited (GBI) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

Summary Genera Biosystems Limited (GBL) is a diagnostic product company. The company develops and commercializes multiplexed molecular diagnostic testing products. Its products include RTIplex and PapType. ...

  • Industries : Pathology
  • Countries : Australia
About 3 300 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Analysis in Australia - Forecast

  • Abstract Introduction: Secondary Prevention Drugs for Cardiac
  • October 2014
    12 pages
  • Drug And Medica...  

    Drug  

  • Australia  

View report >

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.